At Radiant Health, we believe effective weight loss must be medically guided, metabolically sound, and hormonally balanced
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2), The Lancet, 2025
Temperature: The Unflinching Tyrant of Peptide Stability We can't stress this enough: temperature is the single most dominant factor in the degradation equation
In the Metformin in Gestational Diabetes (MiG) trial published in 2008, in which patients were randomized to insulin versus metformin, there was a signal that there was an increased risk for elevated BMI and childhood overweight later in life at age 7 to 9 years in one of the cohorts
Pharmacokinetics and Safety of Long-Acting Release Formulations of Pasireotide (SOM230) in a Male Population: An Open-Label, Phase I Study